Picture of Neofect Co logo

290660 Neofect Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Neofect Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue12,31118,62523,15826,20226,614
Cost of Revenue
Gross Profit3,2272,5256,2477,4908,142
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses26,37333,28330,78733,93333,691
Operating Profit-14,061-14,658-7,629-7,732-7,077
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-16,027-15,461-4,594-9,514-5,578
Provision for Income Taxes
Net Income After Taxes-15,875-15,103-4,863-9,622-5,541
Minority Interest
Net Income Before Extraordinary Items
Net Income-15,845-15,007-5,045-9,621-4,963
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-15,845-15,007-5,045-9,621-4,963
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1,142-1,133-266-493-63.3
Dividends per Share